A study by Liang et al. [83] showed that in contrast to the tumor-promoting activity of Sphk1 [84], a lack of sphignosine kinase 2 (Sphk2) is associated with enhanced expression of Sphk1 and S1P receptor 1 and subsequent colitis-associated cancer development. Here, SPHK1 is linked to cancer.